Patient and Observer Scar Assessment Scale

1. Abstract

The Patient and Observer Scar Assessment Scale (POSAS) is a comprehensive, clinically validated dual-component instrument developed to quantify scar quality following surgical intervention, trauma, burns, and other cutaneous injuries. Originally formulated in 2004 by Draaijers and colleagues (Version 1.0) and refined in 2005 by van de Kar and colleagues (Version 2.0), the instrument was conceived to overcome a critical limitation of traditional scar rating systems: the systematic omission of the patient’s subjective experience. The POSAS is composed of two independent scales: the Observer Scale, completed by a clinician, surgeon, or physical therapist, and the Patient Scale, completed directly by the individual with the scar. Each subscale contains 6 physiological or sensory items rated on a 10-point numeric rating scale ranging from 1 to 10, accompanied by a separate seventh item measuring overall scar impression. The Observer Scale evaluates vascularity, pigmentation, thickness, relief, pliability, and surface area. The Patient Scale captures pain, pruritus (itching), color discrepancy, stiffness, thickness, and irregularity. Summed scores for each 6-item scale range from 6 (representing normal, healthy skin) to 60 (representing the worst imaginable scar state), while the overall opinion items are evaluated separately. Psychometric evaluations across diverse clinical populations—including burn survivors, linear surgical wounds, keloids, and hypertrophic scars—demonstrate high internal consistency (Cronbach’s alpha typically ranging between .76 and .92), acceptable to excellent inter-observer reliability (intraclass correlation coefficients between .73 and .94), and robust convergent validity when compared against objective instrumental measures and legacy scales such as the Vancouver Scar Scale (VSS). By integrating clinician observation with patient-reported outcome measurement, the POSAS provides a holistic biobehavioral evaluation of scarring.

2. Keywords

Patient and Observer Scar Assessment Scale, POSAS, scar assessment, patient-reported outcome measures, wound healing, burn scars, hypertrophic scars, psychometrics, Vancouver Scar Scale, cutaneous aesthetics

3. Authors

The Patient and Observer Scar Assessment Scale was conceptualized, designed, and psychometrically validated through collaborative clinical research groups based in the Netherlands, primarily associated with the Burn Center at the Red Cross Hospital in Beverwijk, the Association of Dutch Burn Centres, and the Department of Plastic, Reconstructive, and Hand Surgery at the Academic Medical Center in Amsterdam.

• Version 1.0 Principal Investigators (2004):
  • Liesbeth J. Draaijers, MD – Burn Center, Red Cross Hospital, Beverwijk, The Netherlands.
  • F. R. Tempelman, MD – Association of Dutch Burn Centres, Beverwijk, The Netherlands.
  • Y. A. Botman – Burn Center, Red Cross Hospital, Beverwijk, The Netherlands.
  • Prof. Dr. R. W. Kreis – Department of Plastic, Reconstructive, and Hand Surgery, Red Cross Hospital, Beverwijk, and Department of Surgery, VU University Medical Center, Amsterdam, The Netherlands.
  • Prof. Dr. E. Middelkoop – Association of Dutch Burn Centres, Beverwijk, and Department of Plastic, Reconstructive and Hand Surgery, Amsterdam UMC, Vrije Universiteit Amsterdam, The Netherlands.
• Version 2.0 Developers (2005):
  • Astrid L. van de Kar, MD – Department of Plastic, Reconstructive, and Hand Surgery, Academic Medical Center, Amsterdam, The Netherlands.
  • L. U. Corion – Academic Medical Center, University of Amsterdam, The Netherlands.
  • Mark J. W. Smeulders, MD, PhD – Department of Plastic, Reconstructive, and Hand Surgery, Academic Medical Center, Amsterdam, The Netherlands.
  • Liesbeth J. Draaijers, MD – Burn Center, Red Cross Hospital, Beverwijk, The Netherlands.
  • Prof. Dr. Chantal M. A. M. van der Horst – Department of Plastic, Reconstructive, and Hand Surgery, Academic Medical Center, University of Amsterdam, The Netherlands.
• Official Instrument Repository: Dedicated information, multilingual translations, and administrative guidance are curated via https://www.posas.nl/.

4. Purpose

The primary purpose of the Patient and Observer Scar Assessment Scale is to provide a standardized, clinically feasible, and psychometrically sound system for assessing the multifaceted severity of cutaneous scars. Following traumatic injury, surgical excision, or thermal trauma, wound healing trajectories deviate along complex biological pathways, frequently resulting in hypertrophic scars, keloids, contractures, or atrophic depressions. Historically, clinical evaluation relied almost exclusively on clinician-administered metrics such as the Vancouver Scar Scale (VSS), introduced by Sullivan and colleagues in 1990. Although the VSS provided a basic taxonomy for vascularity, pigmentation, pliability, and height, it completely ignored subjective patient experiences such as pain and persistent pruritus, and restricted clinicians to narrow categorical tiers that lacked sensitivity to subtle longitudinal changes.

The POSAS resolves these limitations by incorporating two foundational design innovations: first, it implements a paired-instrument design that treats the subjective evaluation of the affected individual as equal in clinical importance to that of the expert clinician. Second, it utilizes uniform 10-point numeric rating scales across all dimensions, providing greater discriminatory power, broader variance capture, and improved tracking of therapeutic response over time.

In clinical practice, the POSAS is utilized across dermatology, plastic and reconstructive surgery, burn therapy, pediatric surgery, physical rehabilitation, and surgical oncology. It serves as an essential measurement tool to:

• Quantify baseline scar severity before initiating interventions such as silicone gel sheeting, intralesional corticosteroid injections, ablative fractional laser resurfacing, or surgical scar revision.
• Objectively monitor therapeutic efficacy across extended post-operative follow-up intervals.
• Identify patient-reported distress that may not correlate directly with visible morphological characteristics (e.g., severe neuropathic itching or hidden stiffness within an otherwise flat scar).
• Bridge communication gaps between patients and healthcare providers by establishing a shared vocabulary for aesthetic and physical wound healing expectations.

In clinical trials, the POSAS serves as a primary or secondary endpoint for regulatory approvals of advanced wound dressings, topical therapies, laser protocols, and tissue engineering matrices, conforming to international guidelines that demand rigorous patient-reported outcome measures (PROMs) alongside objective physiological endpoints.

5. Psychological Construct

The POSAS measures a multidimensional biobehavioral construct defined as Scar Severity and Impairment. This construct encompasses visible morphological changes, biomechanical properties of the dermis, sensory nerve dysfunction, and cognitive appraisals of bodily alteration. The instrument conceptualizes scar evaluation through two distinct yet complementary perspectives: objective anatomical pathology (Observer Scale) and lived sensory and aesthetic distress (Patient Scale).

The Observer Dimensions

• Vascularity: The presence and proliferation of microvasculature within the newly remodeled neodermis. Clinically assessed by examining capillary redness and testing capillary refill time through manual blanching with a transparent piece of Plexiglas. Increased vascularity reflects ongoing inflammation and immature scar remodeling.
• Pigmentation: Melanocytic activity and hyper- or hypopigmentation relative to adjacent, uninjured cutaneous margins. It assesses brownish discoloration caused by melanin or hemosiderin deposits, distinguishing dermal coloration from superficial erythema.
• Thickness: Vertical distance from the deep dermis/subcutis boundary to the highest point of the epidermal layer. It differentiates atrophic lesions (collapsed beneath skin level) from elevated hypertrophic or keloidal tissue formations.
• Relief: Surface topography, texture, and contour irregularities. It captures structural roughness, cobble-stoning, micro-nodularity, and spatial unevenness across the scar surface compared to normal surrounding skin.
• Pliability: Viscoelasticity and extensibility of the tissue, evaluated by physical palpation and pinching between the examiner’s thumb and index finger. It categorizes tissue flexibility, ranging from supple (normal) to leathery, rigid, or contracted states.
• Surface Area: Planar extent of the scar relative to the initial surgical incision or original wound footprint, capturing expansion beyond wound margins (as seen in progressive keloids) or contracture phenomena.
• Overall Opinion (Observer): A holistic gestalt score reflecting the clinician’s total impression of scar severity based on clinical experience, prognosis, and functional impact.

The Patient Dimensions

• Pain: Somatosensory discomfort, tenderness, or lancinating sensations experienced within the scar tissue over preceding weeks. It captures chronic nociceptive or neuropathic signaling driven by regenerating nerve fibers entrapped within dense collagen bundles.
• Itching (Pruritus): Histaminergic or non-histaminergic pruritic signaling within the scar zone. Often described by patients as the most debilitating symptom, chronic itching causes sleep disruption, anxiety, and scratching-induced secondary trauma.
• Color Discrepancy: The patient’s appraisal of how visually mismatched the scar appears compared to adjacent uninjured skin, capturing redness, hyperpigmentation, or depigmentation without requiring clinical differentiation of the biological cause.
• Stiffness: The subjective feeling of physical tightness, inelasticity, or mechanical restriction during active anatomical movement, often preceding measurable joint contracture.
• Thickness: The patient’s perception of vertical scar elevation, swelling, or depth depression, assessing their bodily perception of structural abnormality.
• Irregularity: The patient’s tactile and visual appraisal of skin surface roughness, bumps, ridges, or unnatural textural transitions.
• Overall Opinion (Patient): An evaluative global metric reflecting how distressing, conspicuous, or unacceptable the patient considers their scar, reflecting psychosocial adjustment, body image integration, and overall treatment satisfaction.

6. Theoretical Framework

The POSAS is informed by the biopsychosocial model of health (Engel, 1977) and perceptual-cognitive theories of body image adjustment. Traditional surgical assessment historically operated within a narrow biomedical paradigm: a scar was evaluated purely as an anatomical sequela defined by millimeters of height, chromatic differences, and joint mobility angles. However, extensive clinical research demonstrates a striking disconnect between clinician-measured physical parameters and the psychosocial distress experienced by the individual. A minor linear surgical scar on the jawline may provoke profound psychosocial distress and social anxiety in one patient, while an extensive abdominal burn scar may be well integrated by another.

The framework underlying the POSAS recognizes that a scar is simultaneously an objective physical phenomenon and a subjective sensory and emotional experience. By formulating paired scales with identical metrics, the POSAS captures how physical tissue architecture interacts with personal appraisal:

1. Neuromatrix Theory of Pain and Sensory Signaling: Introduced by Ronald Melzack, this framework conceptualizes pain and dysesthesia (such as post-burn pruritus) as multidimensional neurobiological outputs shaped by sensory inputs, cognitive appraisals, and emotional states. The POSAS integrates these elements into wound tracking by including separate assessments for pain and itching.
2. Cognitive Appraisal Model of Visible Difference: Drawing from the work of Nichola Rumsey and colleagues at the Centre for Appearance Research, this model posits that distress related to altered physical appearance is not directly proportional to the objective size or severity of the visible mark. Instead, it is mediated by internal cognitive appraisals, perceived stigma, social visibility, and disrupted self-concept. The Patient Scale allows individuals to communicate their own somatic and aesthetic perceptions rather than having them inferred by an observer.
3. Psychometric Dual-Perspective Measurement: Methodologically, the scale is designed as an interactive dyad. Clinicians evaluate mechanical and vascular features relevant to surgical prognosis, while patients evaluate tactile, sensory, and daily experiential features. This dual assessment ensures that clinical management addresses both structural healing and patient-centered rehabilitation goals.

7. Validity

The psychometric validity of the POSAS has been evaluated across dozens of clinical investigations worldwide, consistently confirming strong construct, convergent, and divergent validity across a wide range of wound etiologies.

Construct and Convergent Validity

During its initial validation, Draaijers et al. (2004) compared the POSAS against the Vancouver Scar Scale (VSS) across a cohort of post-burn hypertrophic scars. The total scores of the POSAS Observer Scale demonstrated strong, statistically significant correlations with the total VSS score ($r = .89, p < .001$). Individual observer items showed clear convergent validity with matching VSS components: observer vascularity correlated with VSS vascularity ($r = .78$), and observer pliability correlated with VSS pliability ($r = .82$).

van de Kar et al. (2005) corroborated these findings in Version 2.0, demonstrating that the Patient Scale total score correlated significantly with both the Observer Scale total score ($r = .65, p < .001$) and the VSS ($r = .58, p < .001$). While these correlations demonstrate meaningful shared variance, their moderate strength confirms that patient perceptions capture unique subjective variance that cannot be detected by external observation alone.

Objective Criterion Validity

The POSAS has also been validated against objective biophysical measurement technologies:

• Spectrophotometry / Mexameter: Observer vascularity ratings correlate significantly with Mexameter erythema indices ($r = .68$ to $.74$), while observer pigmentation ratings correlate with melanin indices ($r = .61$ to $.71$).
• Cutometer: Observer and patient pliability ratings correlate inversely with Cutometer elastic recovery parameters ($U_e$ and $U_f$, $r = -.52$ to $-.68$), confirming that POSAS pliability scores accurately reflect true mechanical viscoelasticity.
• High-Frequency Ultrasound: Observer thickness ratings correlate closely with dermal thickness measurements obtained via 20-MHz ultrasound ($r = .72, p < .001$).

Discriminant and Known-Groups Validity

The POSAS reliably differentiates between distinct scar pathologies. In comparative clinical trials, hypertrophic scars and keloids consistently yield significantly higher total observer scores (means ranging from 32 to 45) and patient scores (means ranging from 30 to 48) compared to normotrophic linear surgical scars (means typically ranging from 10 to 18; $p < .0001$). Additionally, the instrument shows robust longitudinal responsiveness, demonstrating significant score reductions ($p < .01$) following fractional$CO_2$ laser ablation, pulsed-dye laser therapy, and intralesional triamcinolone acetonide injections.

8. Reliability

The POSAS exhibits strong reliability across diverse patient populations, scar types, and testing contexts. Reliability has been established through internal consistency analyses, test-retest examinations, and multi-rater inter-observer comparisons.

Internal Consistency

Psychometric evaluations consistently confirm high internal consistency for both subscales. In the foundational validation studies by Draaijers et al. (2004) and van de Kar et al. (2005), Cronbach’s alpha for the 6-item Observer Scale ranged between .82 and .86. The 6-item Patient Scale demonstrated similarly robust internal consistency, with alpha coefficients typically ranging between .76 and .88 across varied wound types. In extensive burn cohorts, Truong et al. (2007) and foreign language adaptation cohorts (including Dutch, German, French, Spanish, and Chinese versions) reported total scale Cronbach’s alpha values between .84 and .92.

Inter-Observer Reliability

Inter-rater reliability of the Observer Scale has been evaluated using Intraclass Correlation Coefficients (ICC) across diverse clinician groups (plastic surgeons, dermatologists, burn therapists, and research nurses). For the total Observer Scale score, published ICC values consistently range from .73 to .94, demonstrating substantial to excellent inter-observer concordance. Individual observer items display varying levels of reliability:

• Vascularity: ICC = .75 – .88
• Pigmentation: ICC = .68 – .82
• Thickness: ICC = .78 – .90
• Relief: ICC = .70 – .84
• Pliability: ICC = .75 – .89
• Surface Area: ICC = .62 – .79

Test-Retest Reliability

In stable, mature scars examined across intervals of one to two weeks, the Patient Scale demonstrated high test-retest stability, with intraclass correlation coefficients ranging from .81 to .91. This stability indicates that the Patient Scale reliably captures true subjective symptom burden rather than transient day-to-day fluctuations.

9. Factor Analysis

Structural evaluations using Exploratory Factor Analysis (EFA) and Confirmatory Factor Analysis (CFA) clarify the latent organization of both the Observer and Patient scales.

Observer Scale Factor Structure

EFA conducted on the 6 items of the Observer Scale consistently yields a unidimensional or dominant two-factor structure accounting for over 65% of the total variance:

• Morphological/Structural Factor: High loadings for Thickness (.82 – .88), Relief (.78 – .85), and Pliability (.74 – .81).
• Color/Surface Factor: High loadings for Vascularity (.81 – .87) and Pigmentation (.65 – .76).

Surface Area demonstrates cross-loadings across structural and visual dimensions (.55 – .65). In unidimensional CFA models, the single-factor structural framework exhibits acceptable model fit indices following the inclusion of correlated residuals between thickness and relief: Root Mean Square Error of Approximation ($ ext{RMSEA}$) = .061 to .078, Comparative Fit Index ($ ext{CFI}$) = .94 to .97, and Tucker-Lewis Index ($ ext{TLI}$) = .92 to .95.

Patient Scale Factor Structure

Factor analytical investigations of the Patient Scale consistently isolate a two-factor latent framework:

• Factor 1: Sensory Discomfort (Sensory Factor): Pain (factor loading = .84 – .91) and Itching (factor loading = .82 – .89). These two symptoms measure neurological and inflammatory hyper-reactivity.
• Factor 2: Physical/Appearance Alteration (Physical Factor): Color (loading = .68 – .78), Stiffness (loading = .74 – .82), Thickness (loading = .81 – .86), and Irregularity (loading = .76 – .84).

CFA testing this two-factor model against an undifferentiated unidimensional model confirms superior construct fit: $chi^2 / df < 2.5$,$ ext{CFI} = .97$,$ ext{TLI} = .95$, and$ ext{RMSEA} = .052$ (90% CI [.038, .067]). These structural findings demonstrate that the Patient Scale effectively captures both how the scar feels (neuropathic sensations) and how it appears and moves (biomechanical and aesthetic disruptions).

10. Instrument / Measurement Tool

The Patient and Observer Scar Assessment Scale (POSAS 2.0) is a multi-informant assessment tool consisting of two independent questionnaires.

• Assessment Type: Combined Clinician-Rated Clinical Observation Scale and Self-Report Patient-Reported Outcome Measure (PROM).
• Target Population: Children (with parent/proxy assistance), adolescents, adults, and elderly patients presenting with any scar type (linear surgical, post-traumatic, burn, keloidal, or hypertrophic).
• Item Count:
  • Observer Scale: 6 core items plus 1 separate overall opinion item (7 items total).
  • Patient Scale: 6 core items plus 1 separate overall opinion item (7 items total).
  • Total Instrument Items: 14 items across both scales.
• Administration Time: Approximately 3 to 5 minutes per scale (6 to 10 minutes total).
• Response Format: 10-point rating scale (ranging from 1 = ‘like normal skin’ / ‘no, not at all’ to 10 = ‘worst scar imaginable’ / ‘yes, very much’).
• Scoring and Computational Rules:
  • Each of the 6 core items in both scales is scored on a discrete integer scale from 1 to 10.
  • Total Observer Score: Calculated by summing items 1 through 6. Score range: 6 to 60. A score of 6 reflects tissue indistinguishable from normal skin, while 60 reflects the worst imaginable structural scar pathology.
  • Total Patient Score: Calculated by summing items 8 through 13. Score range: 6 to 60. A score of 6 reflects no symptoms and complete normal appearance, while 60 reflects maximal sensory discomfort and structural disfigurement.
  • Overall Opinion Items: Item 7 (Observer Overall Opinion) and Item 14 (Patient Overall Opinion) are rated on the same 1 to 10 scale but are analyzed separately as global clinical indicators. They are never summed into the 6-item total scores to prevent double-weighting.
  • Missing Data: If more than one item within a 6-item scale is omitted, the total sum score should not be calculated. If a single item is missing, mean imputation of the remaining 5 items may be used with caution in research settings.

11. Permissions & Fee and Test Year

The original POSAS Version 1.0 was published in 2004, and its revised standard format, Version 2.0, was published in 2005. The instrument is governed by the academic creators and the Dutch Burn Centres network. The classical POSAS (Version 2.0) is made broadly accessible for non-commercial academic research, institutional clinical registries, and everyday clinical healthcare delivery. The official scales, administrative manuals, and validated language translations can be reviewed at https://www.posas.nl/.

Commercial clinical trials, pharmaceutical corporate studies, or prospective studies incorporating electronic device implementations (e-POSAS platforms) may require formal licensing, user permission agreements, or registration with the POSAS steering committee. Users are encouraged to cite the foundational publications (Draaijers et al., 2004; van de Kar et al., 2005) in all derived clinical reports and scientific publications.

12. References

• Draaijers, L. J., Tempelman, F. R., Botman, Y. A., Tuinebreijer, W. E., Kreis, R. W., Boxma, H., & Middelkoop, E. (2004). The Patient and Observer Scar Assessment Scale: A reliable and feasible tool for scar evaluation. Plastic and Reconstructive Surgery, 113(7), 1960–1965. https://doi.org/10.1097/01.prs.0000122207.28773.56
• van de Kar, A. L., Corion, L. U., Smeulders, M. J., Draaijers, L. J., van der Horst, C. M., & van Zuijlen, P. P. (2005). Reliable and feasible evaluation of linear scars by the Patient and Observer Scar Assessment Scale. Plastic and Reconstructive Surgery, 116(2), 514–522. https://doi.org/10.1097/01.prs.0000172982.43599.d6
• Sullivan, T., Smith, J., Kermode, J., McIver, E., & Courtemanche, D. J. (1990). Rating the burn scar. Journal of Burn Care & Rehabilitation, 11(3), 256–260. https://doi.org/10.1097/00004630-199005000-00014
• Truong, P. T., Lee, J. C., Kwan, W., Shenouda, G., Nichol, A., Olivotto, I. A., & Wai, E. S. (2007). Patient and Observer Scar Assessment Scale: Comparing clinician and patient ratings of radiation-induced fibrosis. International Journal of Radiation Oncology*Biology*Physics, 69(3), S449–S450. https://doi.org/10.1016/j.ijrobp.2007.07.1643
• Bae, S. H., Bae, Y. C., & Nam, S. B. (2014). Analysis of linear scars using the Patient and Observer Scar Assessment Scale. Archives of Plastic Surgery, 41(6), 721–727. https://doi.org/10.5999/aps.2014.41.6.721
• van der Wal, M. B., Tuinebreijer, W. E., Bloemen, M. C., Verhaegen, P. D., van Zuijlen, P. P., & Middelkoop, E. (2012). Rasch analysis of the Patient and Observer Scar Assessment Scale (POSAS) in burn scars. Quality of Life Research, 21(1), 13–23. https://doi.org/10.1007/s11136-011-9924-5
• Engel, G. L. (1977). The need for a new medical model: A challenge for biomedicine. Science, 196(4286), 129–136. https://doi.org/10.1126/science.847460

13. Items of the Scale (Questionnaire)